What is it about?
In cancer patients, depression causes suffering during the whole disease trajectory and it also influences the personal perception of well-being as well as treatment adherence. Consequently, its better definition is needed for planning more tailored supportive programs. This study was aimed to provide information on depressive state intensity and prevalence in an heterogeneous sample of cancer inpatients.
Featured Image
Why is it important?
The data reinforce the importance of a clinical and research focus on depression in oncology. Since differences according to gender, age, and diagnosis exist in depression prevalence and intensity, tailored supportive intervention should be planned and verified for effectiveness and efficacy.
Perspectives
The main strengths of the current study are the large sample size, the consecutive recruitment that was based on routinely collected clinical data, and the detailed data provided (based on two different cut-off and cross-tabulated for gender and age, gender and diagnosis).
Dr Maria Antonietta Annunziata
Centro di Riferimento Oncologivo
Read the Original
This page is a summary of: Intensity and prevalence of depressive states in cancer inpatients: a large sample descriptive study, European Journal of Cancer Care, June 2016, Wiley,
DOI: 10.1111/ecc.12542.
You can read the full text:
Contributors
The following have contributed to this page
